diclofenac has been researched along with Teeth, Impacted in 36 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Excerpt | Relevance | Reference |
---|---|---|
"Diclofenac sodium is a widely used nonsteroidal anti-inflammatory drug (NSAID) for relief of inflammatory pain." | 6.87 | Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial. ( Ahmed, B; Bulsara, Y; Dietrich, T; Gorecki, P; Pearson, D; Rainsford, KD; Saund, D; Taneja, P, 2018) |
"Postoperative pain was self-recorded by the patients using a numerical rating scale at 24-hour intervals for a period of 72 hours." | 2.87 | Pre-Emptive Effect of Dexamethasone and Diclofenac Sodium Associated With Codeine on Pain, Swelling, and Trismus After Third Molar Surgery: A Split-Mouth, Randomized, Triple-Blind, Controlled Clinical Trial. ( Bagordakis, E; Dos Santos, CRR; Falci, SGM; Lima, TC; Pinheiro, MLP, 2018) |
"Diclofenac sodium is a widely used nonsteroidal anti-inflammatory drug (NSAID) for relief of inflammatory pain." | 2.87 | Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial. ( Ahmed, B; Bulsara, Y; Dietrich, T; Gorecki, P; Pearson, D; Rainsford, KD; Saund, D; Taneja, P, 2018) |
"They reported significantly less postoperative pain at various time points within 24h after surgery and also consumed significantly less rescue medication (paracetamol (acetaminophen)) throughout the study when they took diclofenac combined with codeine than when they took only diclofenac." | 2.84 | Efficacy of oral diclofenac with or without codeine for pain control after invasive bilateral third molar extractions. ( Brozoski, DT; Calvo, AM; Dionisio, TJ; Faria, FAC; Lauris, JRP; Santos, CF; Simoneti, LF; Torres, EA; Weckwerth, GM; Zupelari-Goncalves, P, 2017) |
"No difference was noted regarding trismus in any of the groups." | 2.79 | Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: a randomised, double-blind, crossover study. ( Akbulut, N; Atakan, C; Çölok, G; Üstüner, E, 2014) |
"A nonsignificant reduction in trismus occurred in both treatment groups compared with the placebo group." | 2.79 | Perioperative bromelain reduces pain and swelling and improves quality of life measures after mandibular third molar surgery: a randomized, double-blind, placebo-controlled clinical trial. ( Al-Mashhadani, BA; Majid, OW, 2014) |
"Postoperative pain was assessed with a visual analogue scale at 4, 6, 12, 24, and 48 h postoperatively (p." | 2.77 | Comparative study of tramadol combined with dexamethasone and diclofenac sodium in third-molar surgery. ( Brandão, JR; da Silva, LC; de Assunção Oliveira, AC; de Santana Santos, T; de Sousa Santos, JA; Menezes Júnior, LR, 2012) |
"and group L 8 mg lornoxicam i." | 2.76 | Postoperative analgesia in impacted third molar surgery: the role of preoperative diclofenac sodium, paracetamol and lornoxicam. ( Alanoglu, Z; Demiralp, S; Ozturk, A; Tuzuner Oncul, AM; Ucok, C; Yazicioglu, D, 2011) |
" Pain intensity was measured using the categorical scale and the primary efficacy variable was the summed pain intensity difference over 8 hours after dosing (SPID-8)." | 2.73 | Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial. ( Davis, N; Fricke, J; Krammer, G; Yu, V, 2008) |
"Aceclofenac was more efficient in controlling pain when administered before the surgery." | 2.72 | Analgesic efficacy of aceclofenac after surgical extraction of impacted lower third molars. ( Fontanella, V; Presser Lima, PV, 2006) |
"Postoperative pain is a common phenomenon after surgical extraction of lower third molars (LTM), and its successful control is an essential part of routine oral surgery." | 2.72 | Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac. ( Marković, AB; Todorović, L, 2006) |
"5 mg) vs paracetamol (500 mg) and placebo given in a flexible dosage regimen to treat pain resulting from extraction of impacted third molar teeth." | 2.71 | Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain. ( Gold, MS; Ionescu, E; Kubitzek, F; Liu, JM; Ziegler, G, 2003) |
"More diclofenac anion was absorbed at a quicker rate using the formulation diclofenac sodium softgel 100 mg than Cataflam." | 2.71 | Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. ( Bon, C; Lyon, JA; Peroutka, SJ; Phillips, CL; Shugars, D; Swarbrick, J; Zuniga, JR, 2004) |
"This study compared the analgesic dose-response relationship and tolerability of 3 doses of ProSorb diclofenac K and placebo in the treatment of pain after dental impaction surgery." | 2.71 | Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain. ( Adamson, D; Christensen, S; Hersh, EV; Kiersch, TA; Levin, LM; Lyon, JA; Noveck, R; Watson, G, 2004) |
"Changes in facial swelling and trismus were compared on days 2 and 7 postoperatively." | 2.67 | Randomized double-blind comparison of tiaprofenic acid and diclophenac sodium after third molar surgery. ( Becker, PJ; Grotepass, FW; Roelofse, JA; van der Westhuijzen, AJ, 1994) |
"It is possible to achieve effective postoperative pain prevention by combining bupivacaine and preoperative normal- and sustained-release preparations of diclofenac." | 2.67 | Effective postoperative pain prevention through administration of bupivacaine and diclofenac. ( Hyrkäs, T; Oikarinen, VJ; Paakkari, I; Ylipaavalniemi, P, 1994) |
"The current practice of postoperative pain management among Finnish oral surgeons was evaluated in a two-phase study." | 1.28 | Successful pain management by Finnish oral surgeons. A clinical follow-up study. ( Antila, H; Heinaro, I; Länsineva, A; Lehtinen, R; Salonen, M, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.33) | 18.7374 |
1990's | 12 (33.33) | 18.2507 |
2000's | 8 (22.22) | 29.6817 |
2010's | 11 (30.56) | 24.3611 |
2020's | 2 (5.56) | 2.80 |
Authors | Studies |
---|---|
Chaitanya, NC | 1 |
Badam, R | 1 |
Siva Prasad Reddy, G | 1 |
Alwala, A | 1 |
Srinivas, P | 1 |
Saawarn, N | 1 |
Chintada, S | 1 |
Akhila, M | 1 |
Bontala, P | 1 |
Inamdar, P | 1 |
Mannava, H | 1 |
Gandhewar, T | 1 |
Andrade, NN | 1 |
Aggarwal, N | 1 |
Choradia, S | 1 |
Mathai, PC | 1 |
Nerurkar, S | 1 |
Singh, R | 2 |
Jayam, C | 1 |
Nazeer, J | 1 |
Iqubal, MA | 1 |
Singh, S | 1 |
Lima, CAA | 1 |
Favarini, VT | 1 |
Torres, AM | 1 |
da Silva, RA | 1 |
Sato, FRL | 1 |
Lima, TC | 1 |
Bagordakis, E | 1 |
Falci, SGM | 1 |
Dos Santos, CRR | 1 |
Pinheiro, MLP | 1 |
Gorecki, P | 1 |
Rainsford, KD | 1 |
Taneja, P | 1 |
Bulsara, Y | 1 |
Pearson, D | 1 |
Saund, D | 1 |
Ahmed, B | 1 |
Dietrich, T | 1 |
Brignardello-Petersen, R | 1 |
Akbulut, N | 1 |
Üstüner, E | 1 |
Atakan, C | 1 |
Çölok, G | 1 |
Majid, OW | 1 |
Al-Mashhadani, BA | 1 |
Kaplan, V | 1 |
Eroğlu, CN | 1 |
Zupelari-Goncalves, P | 1 |
Weckwerth, GM | 1 |
Calvo, AM | 1 |
Simoneti, LF | 1 |
Dionisio, TJ | 1 |
Brozoski, DT | 1 |
Torres, EA | 1 |
Lauris, JRP | 1 |
Faria, FAC | 1 |
Santos, CF | 1 |
Tuzuner Oncul, AM | 1 |
Yazicioglu, D | 1 |
Alanoglu, Z | 1 |
Demiralp, S | 1 |
Ozturk, A | 1 |
Ucok, C | 1 |
de Sousa Santos, JA | 1 |
da Silva, LC | 1 |
de Santana Santos, T | 1 |
Menezes Júnior, LR | 1 |
de Assunção Oliveira, AC | 1 |
Brandão, JR | 1 |
Kubitzek, F | 1 |
Ziegler, G | 1 |
Gold, MS | 1 |
Liu, JM | 1 |
Ionescu, E | 1 |
Zuniga, JR | 1 |
Phillips, CL | 1 |
Shugars, D | 1 |
Lyon, JA | 2 |
Peroutka, SJ | 1 |
Swarbrick, J | 1 |
Bon, C | 1 |
Joshi, A | 1 |
Parara, E | 1 |
Macfarlane, TV | 1 |
Hersh, EV | 1 |
Levin, LM | 1 |
Adamson, D | 1 |
Christensen, S | 1 |
Kiersch, TA | 1 |
Noveck, R | 1 |
Watson, G | 1 |
Presser Lima, PV | 1 |
Fontanella, V | 1 |
Marković, AB | 1 |
Todorović, L | 1 |
Fricke, J | 1 |
Davis, N | 1 |
Yu, V | 1 |
Krammer, G | 1 |
Mayer, M | 1 |
Weiss, P | 1 |
van der Westhuijzen, AJ | 1 |
Roelofse, JA | 1 |
Grotepass, FW | 1 |
Becker, PJ | 1 |
Bakshi, R | 2 |
Frenkel, G | 1 |
Dietlein, G | 1 |
Meurer-Witt, B | 1 |
Schneider, B | 1 |
Sinterhauf, U | 1 |
Hyrkäs, T | 3 |
Ylipaavalniemi, P | 3 |
Oikarinen, VJ | 2 |
Paakkari, I | 3 |
Ahlström, U | 1 |
Nilsson, P | 1 |
Wåhlander, L | 1 |
Bailey, BM | 1 |
Zaki, G | 1 |
Rotman, H | 1 |
Woodwards, RT | 1 |
Walton, GM | 1 |
Rood, JP | 1 |
Snowdon, AT | 1 |
Rickwood, D | 1 |
Zacharias, M | 1 |
Hunter, KM | 1 |
Baker, AB | 1 |
Ventä, I | 1 |
Hultin, M | 1 |
Olander, KJ | 1 |
Antila, H | 1 |
Lehtinen, R | 1 |
Heinaro, I | 1 |
Länsineva, A | 1 |
Salonen, M | 1 |
Tai, YM | 1 |
Baker, R | 1 |
Campbell, WI | 1 |
Kendrick, RW | 1 |
Ripari, M | 1 |
Barraco, G | 1 |
Maggiore, C | 1 |
Pacifici, L | 1 |
Frame, JW | 1 |
Rout, PG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Preliminary Evaluation of the Efficacy and Local Tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, Administered Locally Prior to Surgery for the Prevention of Post-operative Pain After Third Molar Surgery[NCT01706588] | Phase 2 | 75 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
Evaluation of Postoperative Edema and Pain Following Third Molar Extraction With Application of Pulsed Electromagnetic Field (PEMF) Therapy[NCT02376946] | 49 participants (Actual) | Interventional | 2014-01-31 | Terminated (stopped due to Sponsor decision) | |||
Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction[NCT03893175] | Phase 1 | 86 participants (Actual) | Interventional | 2019-05-10 | Completed | ||
Single-dose and Multi-dose Open-label Pilot Trial of the Analgesic Efficacy and Tolerability of Intranasal Ketorolac Tromethamine (SPRIX®) in Dental Implant Surgery Patients With Postoperative Pain.[NCT01490931] | Phase 4 | 28 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
Assessment of the Operative Course in Connection With Removal of Lower Third Molars With Particular Consideration to the Occurence of Pain and Swelling[NCT00805298] | 154 participants (Actual) | Interventional | 2008-08-31 | Completed | |||
Efficacy of the Application of Moxifloxacin and Cefixime in Reduction of Inflammatory Sequelae and Complications After Mandibular Third Molar Surgery[NCT05027893] | 157 participants (Actual) | Interventional | 2019-06-07 | Active, not recruiting | |||
Comparing the Efficacy of Local Anesthetics in Mohs Surgery[NCT03871478] | 105 participants (Anticipated) | Interventional | 2019-10-01 | Recruiting | |||
A Randomized, Double-blind, Double-dummy, Parallel Group, Single-center Study Evaluating the Analgesic Effect of Single Doses of Lumiracoxib 400 mg, Celecoxib 400 mg and Placebo in the Treatment of Post-dental Surgery Pain[NCT00348491] | Phase 4 | 364 participants | Interventional | 2006-02-28 | Completed | ||
Effect of Steroids on Post-tonsillectomy Morbidities[NCT02401529] | Phase 2 | 100 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Pain will be scored by the patient at the end of surgery (time 0) and at 15-minute intervals after surgery for a total of 6 hours on a 0-100 mm VAS (from 0 = no pain to 100 = worst pain imaginable). (NCT01706588)
Timeframe: Pain scores will be measured over the time from end of surgery (time 0) to the 6 hour post-surgery
Intervention | mm*minutes (Mean) |
---|---|
Diclofenac Sodium 5 mg/mL | 6843 |
Diclofenac Sodium 12.5 mg/mL | 8832 |
Diclofenac Sodium 25 mg/mL | 9998 |
Diclofenac Sodium 50 mg/mL | 7290 |
Placebo 1 mL | 15539 |
(NCT01490931)
Timeframe: 2 Hours
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 9.1 |
Pain intensity scores will be recorded by patient employing a standard 100 mm visual analog scale (NCT01490931)
Timeframe: 20 minutes post dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 14.3 |
(NCT01490931)
Timeframe: 3 hours post-dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 9.6 |
(NCT01490931)
Timeframe: 4 Hours post-dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 10.0 |
VAS pain intensity score at 40 minutes post-dose (NCT01490931)
Timeframe: 40 minutes post dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 10.1 |
(NCT01490931)
Timeframe: 5 Hours post-dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 16.2 |
(NCT01490931)
Timeframe: 6 Hours post-dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 19.8 |
VAS pain intensity score 60 minutes after dosing. (NCT01490931)
Timeframe: 60 minutes post dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 10.6 |
(NCT01490931)
Timeframe: 90 minutes post-dose
Intervention | millimeters (Mean) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 9.6 |
Measure obtained using recognized double-stop watch technique. Patient is asked to depress the second stop watch when pain relief is meaningful to them. Each patient decides what meaningful relief is for them. (NCT01490931)
Timeframe: At time of depressing meaningful relief stopwatch up to 6 hours.
Intervention | seconds (Median) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 172 |
Self explanatory (NCT01490931)
Timeframe: Up to 5 days
Intervention | days (Number) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 3 |
(NCT01490931)
Timeframe: Up to 5 hours after last suture is placed
Intervention | percentage of participants (Number) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 89 |
Data will be obtained employing the well-described double stop watch technique (NCT01490931)
Timeframe: Censored at 6 hours
Intervention | seconds (Median) |
---|---|
Ketorolac Nasal Spray 31.5 mg (SPRIX) | 86 |
adequacy of meals (inadequate, adequate) (NCT02401529)
Timeframe: 3 days
Intervention | participants (Number) | |
---|---|---|
inadequate | adequate | |
IV Dexamethasone and Oral Prednisolone | 16 | 34 |
Placebo | 27 | 23 |
average frequency of meals (1 meal, 2 meals, if more specify) (NCT02401529)
Timeframe: average number of meals consumed per day for the 1st three days post-surgery
Intervention | participants (Number) | ||
---|---|---|---|
1 meal | 2 meals | 3 meals | |
IV Dexamethasone and Oral Prednisolone | 2 | 20 | 28 |
Placebo | 1 | 34 | 15 |
Postoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify) (NCT02401529)
Timeframe: 7 days
Intervention | participants (Number) | |||
---|---|---|---|---|
no nausea | one day | two days | three days | |
IV Dexamethasone and Oral Prednisolone | 33 | 3 | 14 | 0 |
Placebo | 21 | 8 | 15 | 6 |
4 selections (1 day, 2 days, 3 days, if more specify) (NCT02401529)
Timeframe: number of days at which pain was experienced within the the 1st sevn days post -surgery
Intervention | participants (Number) | ||
---|---|---|---|
one day | two days | three days | |
IV Dexamethasone and Oral Prednisolone | 36 | 11 | 3 |
Placebo | 23 | 19 | 8 |
5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting) (NCT02401529)
Timeframe: The severest pain grade felt within a week
Intervention | participants (Number) | ||
---|---|---|---|
Low disability and low intensity | high disability and moderate intensity | high disability and high intensity | |
IV Dexamethasone and Oral Prednisolone | 37 | 13 | 0 |
Placebo | 26 | 21 | 3 |
Postoperative nausea occurence (yes, no) (NCT02401529)
Timeframe: 7 days
Intervention | participants (Number) | |
---|---|---|
yes | no | |
IV Dexamethasone and Oral Prednisolone | 17 | 33 |
Placebo | 29 | 21 |
Postoperative vomiting occurrence (yes, no) (NCT02401529)
Timeframe: 7 days
Intervention | participants (Number) | |
---|---|---|
yes | no | |
IV Dexamethasone and Oral Prednisolone | 25 | 25 |
Placebo | 36 | 14 |
feeding onset (1st day i. surgery day, 2nd day, 3rd day) (NCT02401529)
Timeframe: Onset of 1st post-operative oral intake recorded within the 1st 3days post-surgery
Intervention | participants (Number) | |
---|---|---|
surgery day | 1st day after surgery | |
IV Dexamethasone and Oral Prednisolone | 46 | 4 |
Placebo | 37 | 13 |
Postoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day) (NCT02401529)
Timeframe: onset of 1st ocurence of nausea attack within the 1st week post-surgery
Intervention | participants (Number) | |||
---|---|---|---|---|
no nausea | immediately | 1st day | immediately and 1st day | |
IV Dexamethasone and Oral Prednisolone | 33 | 10 | 4 | 3 |
Placebo | 21 | 8 | 11 | 10 |
Postoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify) (NCT02401529)
Timeframe: total number of post-operative vomiting episodes which were experienced within the 1st week post-surgery
Intervention | participants (Number) | ||||
---|---|---|---|---|---|
no vomiting | once | twice | three times | more than 3 times | |
IV Dexamethasone and Oral Prednisolone | 25 | 13 | 7 | 4 | 1 |
Placebo | 14 | 9 | 19 | 8 | 0 |
31 trials available for diclofenac and Teeth, Impacted
Article | Year |
---|---|
The effects of systemic proteolytic enzyme therapy on pain and swelling in third molar surgery equal to diclofenac therapy: a prospective randomized double blinded clinical trial.
Topics: Diclofenac; Double-Blind Method; Edema; Enzyme Therapy; Humans; Molar, Third; Pain, Postoperative; P | 2020 |
Oral dexamethasone decreases postoperative pain, swelling, and trismus more than diclofenac following third molar removal: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Dexamethasone; Diclofenac; Double-Blind Method; Edema; | 2017 |
Pre-Emptive Effect of Dexamethasone and Diclofenac Sodium Associated With Codeine on Pain, Swelling, and Trismus After Third Molar Surgery: A Split-Mouth, Randomized, Triple-Blind, Controlled Clinical Trial.
Topics: Adolescent; Adult; Analgesics, Opioid; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Stero | 2018 |
Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Doubl | 2018 |
Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: a randomised, double-blind, crossover study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Diclofenac; Double-B | 2014 |
Perioperative bromelain reduces pain and swelling and improves quality of life measures after mandibular third molar surgery: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Activities of Daily Living; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Anti- | 2014 |
Comparison of the Effects of Daily Single-Dose Use of Flurbiprofen, Diclofenac Sodium, and Tenoxicam on Postoperative Pain, Swelling, and Trismus: A Randomized Double-Blind Study.
Topics: Adolescent; Adult; Anesthesia, Dental; Anesthesia, Local; Anti-Inflammatory Agents, Non-Steroidal; D | 2016 |
Efficacy of oral diclofenac with or without codeine for pain control after invasive bilateral third molar extractions.
Topics: Administration, Oral; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Codeine; Cross-Ov | 2017 |
Postoperative analgesia in impacted third molar surgery: the role of preoperative diclofenac sodium, paracetamol and lornoxicam.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Inflammatory Agents, Non- | 2011 |
Comparative study of tramadol combined with dexamethasone and diclofenac sodium in third-molar surgery.
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid | 2012 |
Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Inflammatory Agents, Non- | 2003 |
Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Inflammatory Agents, Non-Ste | 2004 |
A double-blind randomised controlled clinical trial of the effect of preoperative ibuprofen, diclofenac, paracetamol with codeine and placebo tablets for relief of postoperative pain after removal of impacted third molars.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics; Ascorbic Acid; Codeine; Diclofenac; Double-Blind | 2004 |
Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain.
Topics: Adolescent; Adult; Analgesics; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; H | 2004 |
Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain.
Topics: Adolescent; Adult; Analgesics; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; H | 2004 |
Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain.
Topics: Adolescent; Adult; Analgesics; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; H | 2004 |
Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain.
Topics: Adolescent; Adult; Analgesics; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; H | 2004 |
Analgesic efficacy of aceclofenac after surgical extraction of impacted lower third molars.
Topics: Administration, Oral; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Chi-Square Distribution; C | 2006 |
Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial.
Topics: Adolescent; Adult; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Drug Admin | 2008 |
[Antiphlogistic and analgesic effect of diclofenac sodium after maxillofacial interventions in a double-blind trial].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Do | 1980 |
Randomized double-blind comparison of tiaprofenic acid and diclophenac sodium after third molar surgery.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-S | 1994 |
A placebo-controlled comparative evaluation of diclofenac dispersible versus ibuprofen in postoperative pain after third molar surgery.
Topics: Administration, Oral; Adult; Aged; Diclofenac; Double-Blind Method; Female; Humans; Ibuprofen; Male; | 1994 |
Preoperative intravenous diclofenac for postoperative pain prevention in outpatients.
Topics: Adult; Ambulatory Surgical Procedures; Analysis of Variance; Diclofenac; Double-Blind Method; Female | 1993 |
The analgesic efficacy of diclofenac dispersible and ibuprofen in postoperative pain after dental extraction.
Topics: Administration, Oral; Adolescent; Adult; Analgesia; Diclofenac; Double-Blind Method; Female; Humans; | 1993 |
A double-blind comparative study of soluble aspirin and diclofenac dispersible in the control of postextraction pain after removal of impacted third molars.
Topics: Adolescent; Adult; Aspirin; Diclofenac; Double-Blind Method; Female; Humans; Male; Molar, Third; Pai | 1993 |
Ketorolac and diclofenac for postoperative pain relief following oral surgery.
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, | 1993 |
Effective postoperative pain prevention through administration of bupivacaine and diclofenac.
Topics: Adult; Analysis of Variance; Anesthesia, Dental; Anesthesia, Local; Anesthetics, Local; Anti-Inflamm | 1994 |
Effectiveness of preoperative analgesics on postoperative dental pain: a study.
Topics: Adult; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribut | 1996 |
Thermographic imaging of postoperative inflammation modified by anti-inflammatory pretreatment.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; D | 2001 |
A clinical trial of the analgesic properties of Voltaren (diclofenac sodium).
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Diclofenac; Double-Blind Method; | 1978 |
Comparison of controlled-release ketoprofen and diclofenac in the control of post-surgical dental pain.
Topics: Adult; Delayed-Action Preparations; Diclofenac; Female; Humans; Ketoprofen; Male; Pain Measurement; | 1992 |
Postoperative dental pain--a comparative study of anti-inflammatory and analgesic agents.
Topics: Adolescent; Adult; Aged; Dexamethasone; Diclofenac; Double-Blind Method; Female; Humans; Injections, | 1991 |
A comparison of the analgesic efficacy of flurbiprofen, diclofenac, dihydrocodeine/paracetamol and placebo following oral surgery.
Topics: Adult; Analgesics; Clinical Trials as Topic; Diclofenac; Female; Flurbiprofen; Humans; Male; Pain, P | 1986 |
5 other studies available for diclofenac and Teeth, Impacted
Article | Year |
---|---|
ANALGESIC EFFECT OF INTRAVENOUS ASCORBIC ACID VERSUS ACELCOFENAC POST-TRANSALVEOLAR EXTRACTION: A CASE-CONTROL STUDY.
Topics: Administration, Intravenous; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Dic | 2019 |
Assessment of C-reactive Protein Level and Efficacy of Diclofenac Sodium and Mefenamic Acid in Relieving Pain in Mandibular Impacted Third Molar Surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Diclofenac; Double-Blind Method; Humans | 2021 |
Preemptive submucosal diclofenac may reduce postoperative pain up to 6 hours after surgical mandibular third-molar extraction but may increase adverse effects.
Topics: Diclofenac; Humans; Molar, Third; Pain, Postoperative; Tooth, Impacted | 2018 |
Successful pain management by Finnish oral surgeons. A clinical follow-up study.
Topics: Adult; Analgesics; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug C | 1992 |
[Topical infiltration of diclofenac sodium during extraction of impacted lower 3rd molars].
Topics: Administration, Topical; Adolescent; Adult; Diclofenac; Female; Humans; Male; Mandible; Molar, Third | 1991 |